ATLN
NASDAQ
US
Atlantic International Corp. - Common Stock
$3.51
▲ +$0.00
(+0.00%)
Vol 27K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$77.8M
ROE
-479.4%
Margin
-22.7%
D/E
506.25
Beta
1.19
52W
$1–$8
Wall Street Consensus
7 analysts · Apr 20263
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
LAB
Standard BioTools Inc
$492.2M
OABI
OmniAb Inc
$266.3M
QTRX
Quanterix Corp
$297.1M
TKNO
Alpha Teknova Inc
$203.4M
CDXS
Codexis Inc
$147.2M
QSI
Quantum-Si Inc
$237.0M
LFCR
Lifecore Biomedical Inc
$306.5M
SEER
Seer Inc
$102.1M
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-0.18 | $-0.20 | $-0.02 |
| Dec 2022 | $-3.26 | $-4.00 | $-0.74 |
| Dec 2021 | $-1.63 | $-4.68 | $-3.05 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $107.8M | $129.5M | $102.8M | $102.9M | $110.1M |
| Net Income | -$7.0M | -$68.7M | -$10.7M | -$10.7M | -$10.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -476.2% | -476.2% | -476.2% | -479.4% | -479.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -10.4% | -31.8% | -21.9% | -21.9% | -21.9% | -22.7% |
| Gross Margin | 11.1% | 10.8% | 10.8% | 10.8% | 10.8% | 10.8% |
| D/E Ratio | — | 498.08 | 498.08 | 498.08 | 506.25 | 506.25 |
| Current Ratio | 1.31 | 0.62 | 1.31 | 1.31 | 1.31 | 1.23 |
Key Ratios
ROA (TTM)
-90.5%
P/S (TTM)
0.17
EPS (TTM)
$-2.00
Rev Growth 3Y
+1182.1%
52W High
$7.97
52W Low
$1.16
$1.16
52-Week Range
$7.97
Financial Health
Free Cash Flow
-$1.3M
Net Debt
$78.5M
Cash
$83K
Total Debt
$78.6M
As of Sep 30, 2025
How does ATLN compare to Life Sciences Tools & Services peers?
Peer group: Micro-cap Life Sciences Tools & Services (All) · 44 companies
ATLN valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
0.2
▼
95%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(2.0)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
ATLN profitability vs Life Sciences Tools & Services peers
ROE
-479.4%
▼
1842%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Net margin
-22.7%
▲
19%
above
peers
(-27.8%)
vs Peers
vs Industry
Below avg
Gross margin
10.9%
▼
78%
below
peers
(48.2%)
vs Peers
vs Industry
Weak
ROA
-90.5%
▼
521%
below
peers
(-14.6%)
vs Peers
vs Industry
Weak
ATLN financial health vs Life Sciences Tools & Services peers
D/E ratio
506.3
▲
2086%
above
peers
(23.2)
vs Peers
vs Industry
High debt
Current ratio
1.2
▼
63%
below
peers
(3.3)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▼
14%
below
peers
(1.4)
vs Peers
vs Industry
Less volatile
ATLN fundamentals radar
ATLN
Peer median
Industry
ATLN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ATLN vs peers: key metrics
Latest News
No related news yet